|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Gleevec (Imatinib). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (668)
Cases resulting in a serious event (666)
Cases resulting in death (131)
Cases resulting in life threatening events (50)
Cases resulting in hospitalization (291)
Cases resulting in disability (44)
Cases resulting in other serious reactions (384)
Below is a sample of reports where side effects / adverse reactions may be related to Gleevec (Imatinib). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in female receiving Gleevec (Imatinib)
Reported by a consumer/non-health professional from Germany on 2007-10-31
Patient: female
Adverse reactions / side effects: Pruritus, Fatigue, Pityriasis Rosea, Psoriasis, Headache, Septic Shock, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Gleevec (Imatinib)
Other drugs received by patient: Primaxin; Tavanic
Adverse event in 50 year old female receiving Gleevec (Imatinib)
Reported by a physician from United States on 2007-10-31
Patient: 50 year old female, weighing 64.9 kg (142.7 pounds)
Adverse reactions / side effects: Basedow's Disease, Periorbital Oedema, Surgery, Exophthalmos, Skin Lesion, Radiotherapy, Condition Aggravated
Suspect drug(s):
Gleevec (Imatinib)
Other drugs received by patient: Synthroid
Adverse event in 60 year old male receiving Gleevec (Imatinib)
Reported by a physician from Canada on 2007-10-31
Patient: 60 year old male
Adverse reactions / side effects: Myocardial Infarction
Suspect drug(s):
Gleevec (Imatinib)
Adverse event in 41 year old male receiving Gleevec (Imatinib)
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-31
Patient: 41 year old male
Adverse reactions / side effects: Abdominal Mass, Gastrointestinal Carcinoma, Laparotomy
Suspect drug(s):
Gleevec
Dosage: 400mg / day
Administration route: Oral
Indication: Chronic Myeloid Leukaemia
Start date: 2002-02-18
End date: 2005-01-06
Gleevec
Dosage: 600mg / day
Administration route: Oral
Start date: 2005-01-06
Adverse event in 70 year old female receiving Gleevec (Imatinib)
Reported by a physician from United Kingdom on 2007-10-31
Patient: 70 year old female
Adverse reactions / side effects: Pneumonia, Coagulopathy, Disseminated Intravascular Coagulation, Platelet Count Decreased, Tongue Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Gleevec
Dosage: 400 mg/day
Indication: Gastrointestinal Stromal Tumour
Gleevec
Dosage: 200 mg/day
Adverse event in 77 year old female receiving Gleevec (Imatinib)
Reported by a physician from Japan on 2007-10-31
Patient: 77 year old female
Adverse reactions / side effects: Hypoglycaemia, Altered State of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Gleevec (Imatinib)
Other drugs received by patient: Amaryl; Tenormin; Micardis; Doxazosin Mesylate; Zolpidem
Adverse event in 77 year old female receiving Gleevec (Imatinib)
Reported by a physician from Japan on 2007-10-30
Patient: 77 year old female
Adverse reactions / side effects: Hypoglycaemia, Altered State of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Gleevec (Imatinib)
Other drugs received by patient: Amaryl; Tenormin; Micardis; Doxazosin Mesylate; Zolpidem
Adverse event in 59 year old male receiving Gleevec (Imatinib)
Reported by a individual with unspecified qualification on 2007-10-30
Patient: 59 year old male
Adverse reactions / side effects: Tooth Infection, Parotitis
Suspect drug(s):
Gleevec (Imatinib)
Adverse event in 74 year old male receiving Gleevec (Imatinib)
Reported by a physician from Japan on 2007-10-30
Patient: 74 year old male
Adverse reactions / side effects: Blast Cell Count Increased, Bone Pain, Dyslalia, Liver Disorder, Subdural Haematoma, Haematocrit Decreased, RED Blood Cell Count Decreased, Brain Oedema, Blood Creatinine Increased, Lymphocyte Count Decreased, White Blood Cell Count Decreased, Nausea, Metamyelocyte Count Increased, Pancytopenia, Monocyte Count Increased, Eosinophil Count Increased, Haemoglobin Decreased, Basophil Count Increased, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death, hospitalization, disablity
Suspect drug(s):
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Indication: Chronic Myeloid Leukaemia
Start date: 2004-03-08
End date: 2004-03-15
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2004-03-23
End date: 2004-04-05
Gleevec
Administration route: Oral
Start date: 2004-04-06
End date: 2004-04-12
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2004-04-13
End date: 2004-04-26
Gleevec
Administration route: Oral
Start date: 2004-04-27
End date: 2004-05-24
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2004-05-25
End date: 2004-06-28
Gleevec
Dosage: unk, unk
Administration route: Oral
Start date: 2004-06-29
End date: 2004-09-21
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2004-09-22
End date: 2004-10-12
Gleevec
Administration route: Oral
Start date: 2004-10-13
End date: 2004-11-22
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2004-11-23
End date: 2005-02-22
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2005-04-04
End date: 2005-05-08
Gleevec
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2005-06-06
End date: 2005-06-12
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2005-06-13
End date: 2005-07-03
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2005-07-11
End date: 2005-07-18
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2005-08-01
End date: 2005-09-04
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2005-09-05
End date: 2005-09-14
Other drugs received by patient: Juvela Nicotinate
Adverse event in 76 year old male receiving Gleevec (Imatinib)
Reported by a physician from United States on 2007-10-30
Patient: 76 year old male, weighing 168.0 kg (369.6 pounds)
Adverse reactions / side effects: Brain Natriuretic Peptide Increased, Hypotension, Cardiac Failure Congestive
Adverse event resulted in: hospitalization
Suspect drug(s):
Gleevec (Imatinib)
Other drugs received by patient: Zocor; Lotrel; Levothyroxine Sodium; Allopurinol; Ibuprofen
Adverse event in receiving Gleevec (Imatinib)
Reported by a health professional (non-physician/pharmacist) from Sweden on 2007-10-30
Patient:
Adverse reactions / side effects: Chronic Lymphocytic Leukaemia, White Blood Cell Count Increased
Suspect drug(s):
Gleevec (Imatinib)
Adverse event in 74 year old male receiving Gleevec (Imatinib)
Reported by a physician from Japan on 2007-10-30
Patient: 74 year old male
Adverse reactions / side effects: Blast Cell Count Increased, Bone Pain, Dyslalia, Liver Disorder, Subdural Haematoma, Haematocrit Decreased, RED Blood Cell Count Decreased, Brain Oedema, Blood Creatinine Increased, Lymphocyte Count Decreased, White Blood Cell Count Decreased, Nausea, Metamyelocyte Count Increased, Pancytopenia, Monocyte Count Increased, Eosinophil Count Increased, Haemoglobin Decreased, Basophil Count Increased, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death, hospitalization, disablity
Suspect drug(s):
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Indication: Chronic Myeloid Leukaemia
Start date: 2004-03-08
End date: 2004-03-15
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2004-03-23
End date: 2004-04-05
Gleevec
Administration route: Oral
Start date: 2004-04-06
End date: 2004-04-12
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2004-04-13
End date: 2004-04-26
Gleevec
Administration route: Oral
Start date: 2004-04-27
End date: 2004-05-24
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2004-05-25
End date: 2004-06-28
Gleevec
Dosage: unk, unk
Administration route: Oral
Start date: 2004-06-29
End date: 2004-09-21
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2004-09-22
End date: 2004-10-12
Gleevec
Administration route: Oral
Start date: 2004-10-13
End date: 2004-11-22
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2004-11-23
End date: 2005-02-22
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2005-04-04
End date: 2005-05-08
Gleevec
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2005-06-06
End date: 2005-06-12
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2005-06-13
End date: 2005-07-03
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2005-07-11
End date: 2005-07-18
Gleevec
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2005-08-01
End date: 2005-09-04
Gleevec
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2005-09-05
End date: 2005-09-14
Other drugs received by patient: Juvela Nicotinate
Adverse event in 59 year old male receiving Gleevec (Imatinib)
Reported by a individual with unspecified qualification from Japan on 2007-10-30
Patient: 59 year old male
Adverse reactions / side effects: Multi-Organ Failure, Enterocolitis Bacterial
Suspect drug(s):
Gleevec (Imatinib)
Adverse event in 69 year old female receiving Gleevec (Imatinib)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 69 year old female
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Gleevec (Imatinib)
Adverse event in 50 year old female receiving Gleevec (Imatinib)
Reported by a physician from United States on 2007-10-29
Patient: 50 year old female
Adverse reactions / side effects: Basedow's Disease, Periorbital Oedema, Surgery, Exophthalmos, Skin Lesion, Radiotherapy, Condition Aggravated
Suspect drug(s):
Gleevec (Imatinib)
Adverse event in 56 year old female receiving Gleevec (Imatinib)
Reported by a physician from China on 2007-10-29
Patient: 56 year old female, weighing 42.0 kg (92.4 pounds)
Adverse reactions / side effects: Anaemia, Gastrointestinal Stromal Tumour
Adverse event resulted in: death
Suspect drug(s):
Gleevec (Imatinib)
Adverse event in 74 year old female receiving Gleevec (Imatinib)
Reported by a health professional (non-physician/pharmacist) on 2007-10-29
Patient: 74 year old female
Adverse reactions / side effects: HIP Arthroplasty, Nausea, Spondylolisthesis, Alopecia
Adverse event resulted in: hospitalization
Suspect drug(s):
Gleevec
Dosage: 400mg/unk
Indication: Chronic Myeloid Leukaemia
Start date: 2005-02-09
Gleevec
Dosage: 600mg/unk
Adverse event in 75 year old male receiving Gleevec (Imatinib)
Reported by a physician from Spain on 2007-10-29
Patient: 75 year old male
Adverse reactions / side effects: Colon Cancer
Suspect drug(s):
Gleevec (Imatinib)
Adverse event in male receiving Gleevec (Imatinib)
Reported by a physician from France on 2007-10-29
Patient: male
Adverse reactions / side effects: Hydrocele
Suspect drug(s):
Gleevec (Imatinib)
Adverse event in 73 year old male receiving Gleevec (Imatinib)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-26
Patient: 73 year old male, weighing 107.0 kg (235.4 pounds)
Adverse reactions / side effects: Upper Respiratory Tract Infection, Hypomagnesaemia, Hypocalcaemia, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cisplatin
Indication: non-Small Cell Lung Cancer
Start date: 2007-09-26
End date: 2007-09-26
Gleevec
Dosage: dose: 400 mg qd for 7 days (from day -5 to day +2)
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Taxotere
Indication: non-Small Cell Lung Cancer
Start date: 2007-09-26
End date: 2007-09-26
Adverse event in 46 year old receiving Gleevec (Imatinib)
Reported by a physician from United Kingdom on 2007-10-26
Patient: 46 year old
Adverse reactions / side effects: Acute Lymphocytic Leukaemia, Acute Myeloid Leukaemia, Neutropenic Sepsis, Transplant
Suspect drug(s):
Gleevec
Dosage: 400 mg/day
Indication: Chronic Myeloid Leukaemia
Gleevec
Dosage: 200 mg/day
Adverse event in 44 year old male receiving Gleevec (Imatinib)
Reported by a consumer/non-health professional from Taiwan, Province of China on 2007-10-26
Patient: 44 year old male
Adverse reactions / side effects: Nephrolithiasis, Renal Colic
Suspect drug(s):
Gleevec (Imatinib)
Adverse event in male receiving Gleevec (Imatinib)
Reported by a physician from United States on 2007-10-26
Patient: male
Adverse reactions / side effects: Atrial Fibrillation, Oedema, Thrombocytopenia
Suspect drug(s):
Gleevec (Imatinib)
Adverse event in 39 year old male receiving Gleevec (Imatinib)
Reported by a individual with unspecified qualification from Japan on 2007-10-26
Patient: 39 year old male
Adverse reactions / side effects: Mechanical Ventilation, Status Epilepticus, Pyrexia, Disorientation, Rash, Convulsion, Pruritus Generalised, Encephalitis Herpes, Human Herpes Virus 6 Serology Positive, Memory Impairment, Altered State of Consciousness
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Alkeran
Dosage: 135 g/d
Start date: 2007-01-15
End date: 2007-01-15
Fludara
Dosage: 42 g/d
Start date: 2007-01-10
End date: 2007-01-14
Foscarnet
Gleevec
Dosage: 800 mg/d
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
End date: 2007-01-15
Gleevec
Dosage: 600/d
Administration route: Oral
Start date: 2007-05-01
Other drugs received by patient: Diflucan; Urso 250; Zovirax; Denosine; Methotrexate; Tacrolimus
Adverse event in female receiving Gleevec (Imatinib)
Reported by a physician from Germany on 2007-10-25
Patient: female, weighing 135.0 kg (297.0 pounds)
Adverse reactions / side effects: Skin Ulcer, Dermatitis, Skin Erosion, Skin Atrophy, Excessive Granulation Tissue
Suspect drug(s):
Gleevec (Imatinib)
|
